Our regulatory specialists take active roles in shaping key industry bodies including the European and United States Pharmacopoeia, EXCiPACT™ and IPEC. They have extensive experience in the submission and progression of new monographs and are practised in supporting the use of novel and innovative excipients in customer formulations.